1-888-578-4754 • 24/7 1-888-578-4754 • 24/7 GET FREE ADVICE
The call is free. The advice is free.
Looking for Answers?

Have you been diagnosed with pancreatic cancer or thyroid cancer?

Have you lost a loved one to these cancers?

Could diabetes drugs be to blame? Contact us to find out the deadline for filing a claim in the United States.

Free Case Review

  • This field is for validation purposes and should be left unchanged.

You pay us nothing unless we win your case.

  • You Have Questions
  • We Have Answers
  • We Get Results

Diabetes Drugs and Cancer

Our diabetes drug lawsuit attorneys are helping individuals nationwide who have been diagnosed with Pancreatic Cancer or Thyroid Cancer after taking diabetes medications like Januvia or Byetta. If you or a loved one developed cancer after taking diabetes drugs, you may be eligible to file Januvia lawsuit or Byetta lawsuit settlement claims in 2015. Call 1-888-578-4754 today for a free, no-obligation case review.

On March 14, 2013, the FDA announced a new investigation of the possible link between certain diabetes drugs and pancreatic cancer.1 The Agency stated that it was evaluating unpublished research which may show that diabetics on certain medications are at an increased risk of pancreatitis and pre-cancerous pancreatic growths.

Before this FDA investigation was announced, a number of scientific studies indicated an elevated risk of pancreatic cancer in patients prescribed medications from a class of diabetes drugs called incretin mimetics.

Researchers Investigate Byetta and Januvia Pancreatic Cancer

Incretin mimetics treat type 2 diabetes by causing the body to produce more insulin. Some, like Byetta and Victoza, increase levels of GLP-1, a hormone that stimulates insulin secretion. Others, like Januvia, Onglyza, Tradjenta, and Nesina, prevent a protein called DPP-4 from breaking down GLP-1. Both types are effective diabetes medications, but, unfortunately, may be linked to potentially deadly side effects like acute pancreatitis and pancreatic cancer.

In 2011, a study by researchers at UCLA found that patients prescribed two incretin mimetics, Byetta and Januvia, were at a six-times-greater risk of pancreatitis than diabetics on other treatments.2 The researchers noted that the rates of pancreatic cancer in patients taking Byetta and Januvia were 2.9 and 2.7 times greater, respectively, than the cancer rates of diabetes patients on other kinds of treatments.

Byetta May Also Be Linked to Thyroid Cancer

Among patients taking Byetta (exenatide) the risk of thyroid cancer also appeared elevated; exenatide users reported thyroid cancer at 4.7 times the rate of other diabetics. Dr. Peter Butler, the chairman of endocrinology at UCLA, warned that the results of the study were preliminary and did not definitively show that incretin mimetics cause cancer.  However, he has publicly stated that he does not prescribe incretin mimetics to his own patients.

Diabetes Drug Lawsuit Attorney

Our law firm represents those who have developed pancreatic or thyroid cancer after taking certain diabetes medications, as well as the families of individuals who died of pancreatic cancer after taking one of these drugs. We represent all clients on a contingency basis, which means there are never any legal fees unless we win compensation in your case.

Contact us for a free legal consultation and a diabetes drug lawsuit attorney will be available to answer your questions about diabetes drugs and cancer.

1.  Food and Drug Administration 3/14/2013
2.  Gastroenterology 2/21/2011

Diabetes Drug Cancer Lawsuit Featured News

Diabetes Drug Makers Ask MDL Judge To Throw Out Insufficient-Warning Claims

by Stephen Fields on August 31st, 2015

Januvia, Janumet, Byetta and Victoza, prescribed to diabetics to help regulate their blood sugar levels, are being blamed for thousands of cases of pancreatic cancer. The manufacturers are already facing more than 700 diabetes drug cancer lawsuit claims from injured patients. Many more are expected to be filed this year. Due to their growing number, the cases have been organized in a multidistrict litigation (MDL) under Judge Anthony Battaglia in California.

Number of Pancreatic Cancer and Diabetes Drug Lawsuits Continues To Grow As Study Investigates Risk

by Stephen Fields on May 26th, 2015

The Milwaukee-Wisconsin Journal Sentinel recently investigated the number of deaths and hospitalizations linked to a small number of diabetes drugs that occurred between 2004 and 2014. Researchers found that Januvia (sitagliptin) was responsible for 964 deaths and 4,425 hospitalizations. Byetta (exenatide) was blamed for 880 deaths and 7,115 hospitalizations. Victoza (liraglutide) is believed to have caused 319 deaths and 2,827 hospitalizations.

What Is The Connection Between Diabetes Drugs And Pancreatic Cancer?

by Stephen Fields on May 18th, 2015

Scientific research has demonstrated that use of diabetes drugs like Januvia and Byetta may increase the risk of pancreatic cancer. This type of cancer is difficult to treat successfully. Most diagnosed cases end in death. Hundreds of Januvia lawsuits, Byetta lawsuits and Victoza lawsuits have been filed on behalf of injured users across the U.S.

Months-Long Investigation of Diabetes Drug FDA Approval Process Offers Several Startling Insights

by Stephen Fields on May 12th, 2015

MedPage Today and the Milwaukee Journal Sentinel joined forces to investigate how diabetes drugs, such as Januvia and Byetta, gain FDA approval. The researchers uncovered multiple studies demonstrating a potentially causal link between diabetes drugs like Januvia and an increased risk of pancreatic cancer. Among those that discovered the possible connection, the majority may underestimate the number of hospitalizations and deaths attributed to such medications.

Did Diabetes Drug Manufacturers Redefine Diabetes To Stimulate Sales?

by Stephen Fields on April 27th, 2015

More than 29 million people in the U.S. have diabetes. Nearly 90 million more are considered pre-diabetic. It’s no surprise that drugs prescribed to diabetics and prediabetics – for example, Januvia, Byetta, Victoza and Onglyza – generate in excess of $20 billion a year in sales.

Nationwide Claims Help

Click on your state for more information or call 1-888-578-4754.

AL AK AZ AR CA CO CT DE FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY DC